Tamoxifen, 17beta-oestradiol and the calmodulin antagonist J8 inhibit human melanoma cell invasion through fibronectin
about
Identification of the Calmodulin-Binding Domains of Fas Death ReceptorIdentification of genes possibly related to storage root induction in sweet potato.Calmodulin antagonists induce cell cycle arrest and apoptosis in vitro and inhibit tumor growth in vivo in human multiple myeloma.A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins.Investigation of female survival benefit in metastatic melanoma.Anti-inflammatory and anti-invasive effects of alpha-melanocyte-stimulating hormone in human melanoma cells.Effect of estrogens on skin aging and the potential role of SERMs.Structural and biophysical characterization of the interactions between the death domain of Fas receptor and calmodulin.Estrogens, estrogen receptors and melanoma.TNF-alpha increases human melanoma cell invasion and migration in vitro: the role of proteolytic enzymes.Tehranolide inhibits cell proliferation via calmodulin inhibition, PDE, and PKA activation.Tamoxifen accelerates proteasomal degradation of O6-methylguanine DNA methyltransferase in human cancer cells.Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A.The combination of calmodulin antagonists and interferon-gamma induces apoptosis through caspase-dependent and -independent pathways in cholangiocarcinoma cells.Characterization of an in vitro model of human melanoma invasion based on reconstructed human skin.Multiple responses to EGF receptor activation and their abrogation by a specific EGF receptor tyrosine kinase inhibitor.
P2860
Q28552166-4E12AF82-F2BA-4AD8-95F6-E84B6DD9879BQ30886799-3BFF2CE7-7FA0-4D65-A96F-0DE45DA48EBAQ34645276-10536775-A06B-479E-961E-BDC120B9C2BFQ35319993-8BB7479D-2A2A-4A6C-B281-A4B79CADCFE1Q36620606-368CF96F-FD7E-455B-BCE1-5474F00418F4Q36671614-255383F2-9BFC-4F2D-8830-BF479C1FDC6AQ37017419-E712F9A8-C9E8-4683-9F06-09D518BDA21DQ37048442-D07044CA-D8F5-4EBD-9C5E-8F7803F1DEFBQ37873466-C3903527-EB8C-430E-8D8F-CD2D683260BAQ38305465-61F6CEF6-30A1-4432-8A95-EFB3C98F6513Q39063796-C580B0C6-E3B2-4899-88ED-46491441F3C6Q40114287-657C1737-2728-4215-B5E2-7180E36E0720Q40143851-CD898B28-D13E-419A-8A19-E739A04CD32AQ40623138-0E0D6859-0DEE-4E0C-8FE5-2552CFBEA188Q40891818-F9FEA3AD-AC01-4DE1-817A-FA7D87A88E75Q43981261-619F5F2B-456B-4F2A-952D-CB293A4DE110
P2860
Tamoxifen, 17beta-oestradiol and the calmodulin antagonist J8 inhibit human melanoma cell invasion through fibronectin
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Tamoxifen, 17beta-oestradiol a ...... l invasion through fibronectin
@ast
Tamoxifen, 17beta-oestradiol a ...... l invasion through fibronectin
@en
type
label
Tamoxifen, 17beta-oestradiol a ...... l invasion through fibronectin
@ast
Tamoxifen, 17beta-oestradiol a ...... l invasion through fibronectin
@en
prefLabel
Tamoxifen, 17beta-oestradiol a ...... l invasion through fibronectin
@ast
Tamoxifen, 17beta-oestradiol a ...... l invasion through fibronectin
@en
P2093
P2860
P356
P1476
Tamoxifen, 17beta-oestradiol a ...... l invasion through fibronectin
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1997.153
P407
P577
1997-01-01T00:00:00Z